Chemical structure of cetirizine
Find information on thousands of medical conditions and prescription drugs.

Zyrtec

Cetirizine hydrochloride is a medication used for the treatment of allergies, hay fever, angioedema, and hives. It is a second-generation H1-receptor antagonist antihistamine and works by blocking H1 histamine receptors. It is a major metabolite of hydroxyzine, and has the same basic side effects, including dry mouth. more...

Home
Diseases
Medicines
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Zafirlukast
Zagam
Zalcitabine
Zaleplon
Zanaflex
Zanamivir
Zantac
Zarontin
Zelnorm
Zerit
Zestoretic
Zestril
Zetia
Zevalin
Ziagen
Zidovudine
Zileuton
Ziprasidone
Zithromax
Zocor
Zofran
Zoladex
Zoledronic acid
Zolmitriptan
Zoloft
Zolpidem
Zometa
Zomig
Zonegran
Zonisamide
Zopiclone
Zosyn
Zovia
Zovirax
Zyban
Zymar
Zyprexa
Zyrtec
Zyvox
  • It has long duration of action
  • No reported cardiac toxicity associated with the use of this drug
  • Minimal penetration of the blood-brain barrier
  • Only mild sedating effects, although more than some other non-sedating antihistamines

The medication is produced by UCB, a Belgian pharmaceutical company. The drug is marketed under the following brand names: Zyrtec® in the USA, Zirtek® in the United Kingdom, Zyrlex® in many other European countries, Reactine® in Canada (all by Pfizer ), and as Virlix® in Mexico and parts of Europe (by GlaxoSmithKline ). It can be found under a variety of other brand names in other countries .

Like many other antihistamine medications, cetirizine is commonly prescribed in combination with pseudoephedrine hydrochloride, a decongestant. These combinations are marketed using the same brand name as the cetirizine with a "-D" suffix (Zyrtec-D®, Virlix-D®, etc.)

Read more at Wikipedia.org


[List your site here Free!]


Switch to OTC for allergy drugs favored by FDA committee - Claritin, Allegra, Zyrtec - Brief Article
From Drug Store News, 6/25/01

The FDA's Nonprescription Drugs and Pulmonary and Allergy Drugs Advisory Committees recommended over-the-counter status for Schering-Plough's Claritin (loratadine), Aventis' Allegra (fexofenadine HCl) and Pfizer's Zyrtec (cetirizine HCl). Initiating the move was WellPoint Health Networks, health insurer to close to 50 million covered lives through Blue Cross of California, Blue Cross and Blue Shield of Georgia and other networks. It is widely thought the move is in response to growing health insurer resistance to foot the bill for highly advertised drugs such as antihistamines, while shifting more of the cost to consumers.

"We are pleased and encouraged that the committees agreed with our assertion that these drugs are safer and as effective as the antihistamine drugs that are currently available OTC and do not meet the FDA criteria for prescription status," said Robert Seidman, Pharm.D., and chief pharmacy officer of WellPoint. It may take significant time for definitive action to be taken on the committee's recommendation.

COPYRIGHT 2001 Lebhar-Friedman, Inc.
COPYRIGHT 2001 Gale Group

Return to Zyrtec
Home Contact Resources Exchange Links ebay